• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

News

Article

Grant Opportunities from the Hidradenitis Suppurativa Foundation: Supporting Innovation and Expertise in HS Research and Care

Key Takeaways

  • The Danby Research Grant supports early-stage investigators with $5,000 to $20,000 for projects improving HS patient care, focusing on disease mechanisms and therapeutic strategies.
  • The Translational Research Grant offers up to $75,000 for one-year projects bridging basic science and clinical practice, aiming for long-term funding from agencies like NIH.
SHOW MORE

The Hidradenitis Suppurativa Foundation offers grants for HS research and clinical expertise, supporting early-stage to established investigators.

Research chemists analyzing data in laboratory
Image Credit: © borovikk - stock.adobe.com

The Hidradenitis Suppurativa Foundation (HSF) offers a range of grant opportunities designed to advance research and clinical expertise in hidradenitis suppurativa (HS). These grants aim to support researchers at different career stages, from early investigators to established practitioners, by providing funding to develop new treatment insights, improve patient care, and stimulate innovative, translational research. Below is an overview of the available grants:

  • Danby Research Grant: This grant seeks to promote clinical and translational research projects that can meaningfully improve patient care in the field of HS. Researchers are invited to submit applications that propose new approaches to understanding HS, including studies on disease mechanisms, therapeutic strategies, or patient-centered care models. Award amounts range from $5,000 to $20,000, allowing researchers flexibility to design studies that fit their project scope. A minimum of five grants may be awarded annually, subject to funding availability. This grant is ideal for early-stage investigators, as priority is given to applicants who are new to HS research. Application deadline: December 9, 2024
  • Translational Research Grant: Aimed at encouraging novel research capable of attracting long-term funding from the National Institutes of Health (NIH) or similar agencies, this grant supports innovative approaches in HS research. Eligible researchers can apply for up to $75,000 to fund one-year projects. The goal is to bridge the gap between basic science and clinical practice, enabling researchers to conduct studies that have the potential to translate directly into improved patient outcomes. Applications are welcome from early-stage investigators and collaborative research teams within an institution. Application deadline: December 9, 2024
  • Mentored Experience Grant: This grant supports trainees and early-career faculty interested in gaining hands-on experience in managing HS under the guidance of an established HS expert. The award provides up to $4,000 to fund up to four weeks of mentored clinical practice and procedural training. This unique opportunity aims to nurture the next generation of HS specialists by creating pathways to learn from seasoned practitioners and enhance skills in clinical care, research, and patient education. Priority is given to applicants from areas without access to an HS clinic. Application deadline: January 31, 2025.

All applicants will be notified of acceptance at the American Academy of Dermatology Annual Meeting in March 2025.

For more information on each grant and application instructions, please visit the respective links provided.

© 2024 MJH Life Sciences

All rights reserved.